Chairpersons : Dr. Maheboob Basade, Dr. Vikram Mathews
09:00 – 09:05 Session introduction
09:05 – 09:30 Nuances in Automated and Decentralized CAR-T Cell Manufacture
Speaker : Dr. Boro Dropulic
09:30 – 09:40 Q & A
Lead Discussant : Dr. Chetan Dhamne
Chairpersons : Dr. Anita Ramesh, Dr. Reetu Jain
Session USA Time:- 23:10 - 23:50
09:40 - 09:45 Session introduction
09:45 - 10:10 Immunotherapy (Antibodies (ADCs and BiTEs), checkpoint inhibitors, CD47) in hematological malignancies
Speaker : Dr. Naval G. Daver
10:10 - 10:20 Q & A
Lead Discussant : Dr. Hemant Malhotra
Chairpersons: Dr. Purna Kurkure, Dr. Pankaj Malhotra
Session USA Time:- 00:50 - 01:30
10:20 - 10:25 Session introduction
10:25 - 10:50 CAR-T Cells : Beyond CD19
Speaker : Dr. Nirali Shah
10:50 - 11:00 Q & A
Lead Discussant : Dr. (Surg Cdr) Gaurav Narula
USA Time:- 01:30 - 02:15
11:00 - 11:25 CAR-T cell therapy in rare and challenging situations (Extreme of ages, comorbidities, CNS disease)
Speaker : Dr. Aditi Shastri
Chairpersons: Dr. Purvish Parikh, Dr. Sunil Arora
11:25 - 11:30 Session introduction
11:35 - 11.45 CAR-T cell therapy : Indian context
Speaker : Dr. Rahul Purwar
11:45 - 11:55 Q & A
Lead Discussant : Vivek Radhakrishnan
Chairpersons : Dr. Tapan Saikia, Dr. Lalit Kumar
Session Sydney Time:- 16:20 - 17:00
11:55 - 12:00 Session introduction
12:00 - 12:25 Applications of adoptive immunotherapy following intensive therapy in oncology
Speaker : Dr. David Gottlieb
12:25 – 12:35 Q & A
Lead Discussant : Prashant Mehta
Chairpersons : Dr. Prakash Chitalkar, Dr. Soumen Basak
12:35 - 13:15 Panel discussion : Immunotherapy in haematolymphoid malignancies - Its potential and future promise
Moderator : Dr. Manju Sengar
Panelist : Dr. Ashish Bakshi, Dr. Rahul Purwar, Dr. Hari Menon, Dr. Sameer Bakhshi, Dr. Hasmukh Jain, Dr. Vipul Sheth, Dr. Abhay Bhave, Tulika Seth
13:15 - 13:25 Indian Data Presentation
National Centres : Dr. George Abraham